Riley Jeffrey Scott
Gain Therapeutics, Inc. · Director
Riley Jeffrey Scott is listed in filings as Director at Gain Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 25, 2025, including 2 public disclosures. Recent filings connect the profile to Gain Therapeutics, Inc. (GANX). The current snapshot covers public activity from Jun 26, 2024 to Jun 25, 2025. Reported amounts are shown as $19.4K to $26.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||